Cambodia Hep-C
Worldwide, an estimated 71 million people are infected with the hepatitis C virus, double the number living with HIV.

While hepatitis C can be cured, few people have access to treatment.

A blood-borne virus that attacks the liver, hepatitis C kills nearly 400,000 people each year, mostly from resulting complications, usually cirrhosis or liver cancer.

While hepatitis C is found worldwide, the vast majority of people with the disease live in developing countries; China, India, Egypt and Indonesia are particularly affected.

Hepatitis C is a curable disease, but millions don't have access to treatment due to high prices.

 
Website

MSF Access Campaign

msfaccess.org

Quick facts about hepatitis C

When Big Pharma plays for keeps, who wins and who loses? (ENG)
video

When Big Pharma plays for keeps, who wins and who loses? (ENG)

When Big Pharma plays for keeps, who wins and who loses?

In this video, we follow the development of sofosbuvir, a true breakthrough drug for hepatitis C, a severe virus that attacks the liver and can be deadly.

The story of sofosbuvir illustrates how research and development for new prescription drugs really works.

After a scientist who got millions in tax-dollars started a small company that did the long work of discovering a new medicine, and showed that it was safe and effective, a giant corporation bought up the next big blockbuster drug and cashed in.

As the new owner of sofosbuvir, Gilead continued clinical trials to learn more about the drug’s effectiveness, safety, side-effects and dosage before seeking government approval to bring the new drug to market.

Gilead first set the price for sofosbuvir at $1000 per pill. That made its worth per gram 67 times greater than gold, but research shows that it only costs $42 to produce.

 
MSF Clinic Hepatitis C Unit
Hepatitis C

MSF joins Europe-wide action challenging patent on key hepatitis C drug

Press Release 26 Mar 2017
 
Killer diseases

Seven killer diseases under the microscope

Documentary 27 Jan 2017
 
Seeking malaria treatment around Aweil, South Sudan
Access to medicines

MSF urges governments to set medical research policies that align with people’s health needs

Press Release 13 Sep 2016
 
MSF TB Treatment in Mumbai, India
India

At EU-India Summit, India must defend its pharmacy of the developing world

Press Release 29 Mar 2016
 
MSF Clinic Hepatitis C Unit - Noor Alam #3
Pakistan

Stories from patients cured of hepatitis C at MSF’s Machar Clinic in Karachi

Voices from the Field 9 Mar 2016
 
MSF Clinic Hepatitis C Unit
Pakistan

When they are diagnosed with hepatitis C, patients think they will die

Voices from the Field 9 Mar 2016
 
Hepatitis C in Mumbai
India

Patent challenge hearing on Gilead hepatitis C drug sofosbuvir starts in India

Project Update 26 Feb 2016
 
India

Indian generic companies should reject Gilead’s controversial hepatitis C ‘Anti-Diversion’ programme

Press Release 19 Mar 2015
 
M'Poko (MPoko) camp (Bangui airport area)
Hepatitis C

Global response to hepatitis C hangs on access to new oral drugs

Press Release 8 Apr 2014
Advanced HIV management in Homa Bay
Medical Resource

MSF Field Research

We produce important research based on our field experience. So far, we have published articles in over 100 peer-reviewed journals. These articles have often changed clinical practice and have been used for humanitarian advocacy. All of these articles can be found on our dedicated Field Research website.

Visit site